NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
Back to search
Official data from USPTO
ONCOREVEAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOREVEAL
ST13
US500000090980823Class
1, 5, 9
Filing
90980823
Registration
7347499
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
04/02/2024
Trademark type
Word
Nice classes
1, 5, 9
Filing date
02/17/2021
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/16/2022
First use in commerce
03/16/2022
Drawing code
4
Owner type
03
Owner location
Natick, MA, US
Examiner
CLYBURN, CARLA DIONNE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pillar Biosciences, Inc.
Representatives
Andrew T. Pettit PERKINS COIE LLP
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents and reagent kits comprising nucleic acidsnaturally occurring and modified nucleotidesenzymesbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationstranscriptionsexpressionswith the aforementioned reagents and reagent kits being in the fields of scientific researchclinical researchscientific diagnostics research; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for scientific researchclinical researchscientific diagnostics research; biological and biochemical kits for scientific researchclinical researchscientific diagnostics research
Class 5
Reagents and reagent kits comprising nucleic acidsnaturally occurring and modified nucleotidesenzymesbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationstranscriptionsexpressionswith the aforementioned reagents and reagent kits being for medical diagnostic purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical diagnostic purposes; biological and biochemical kits comprised of diagnostic preparations for medical purposesfor the diagnosis and treatment of cancer; biological and biochemical kits for medical diagnostic purposes
Class 9
Downloadable computer software for the collectionmanagementanalysis of data for use in the fields of scientific researchclinical researchscientific diagnosticsmedical diagnostics; downloadable computer software for analyzing biological samples; downloadable computer software for analyzing biological samples for medical purposesfor the diagnosis and treatment of cancer; downloadable computer software for use with reagents and reagent kitsall for the purpose of detectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsall in the fields of scientific researchclinical researchscientific diagnostics researchmedical diagnostics; downloadable computer software for bioinformatics and gene expression microarray image analysisgene expression quantificationgene image processinggene information processing; downloadable computer software for health and wellness assessmentfor use in genomic analysis; downloadable computer software for genetic and bioinformatics analysis
Publications
History of USPTO decisions and trademark events.
58 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/24/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/23/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
02/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/31/2024
DRRR
DIVISIONAL REQUEST RECEIVED
01/30/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/30/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/30/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/30/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/31/2023
GNRT
NON-FINAL ACTION E-MAILED
07/31/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2023
ALIE
ASSIGNED TO LIE
07/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2022
GNRT
NON-FINAL ACTION E-MAILED
09/08/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/11/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/10/2022
EX1G
SOU EXTENSION 1 GRANTED
08/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/10/2022
IUAF
USE AMENDMENT FILED
08/01/2022
EXT1
SOU EXTENSION 1 FILED
08/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/01/2022
EISU
TEAS STATEMENT OF USE RECEIVED
08/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/01/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/29/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/30/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/21/2021
GNRT
NON-FINAL ACTION E-MAILED
09/21/2021
CNRT
NON-FINAL ACTION WRITTEN
09/21/2021
DOCK
ASSIGNED TO EXAMINER
09/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/21/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
02/23/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/23/2021
NWAP
NEW APPLICATION ENTERED
02/20/2021
Continuous trademark protection
Get notified about every new filing that threatens ONCOREVEAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.